Effect of insulinotropic agent nateglinide on Kv and Ca 2+ channels in pancreatic -cell

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.427, Iss.2, 2001-09, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nateglinide: a new rapid-acting insulinotropic agent

By Kumar Sudhesh Hanif Wasim

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1027-1031

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Nateglinide: A Rapidly-Absorbed, Short-Acting Insulinotropic Agent

By McLeod J.F.

Clinical Pharmacokinetics, Vol. 43, Iss. 2, 2004-01 ,pp. : 97-120

Adis International

Access to resources Recommend Favorite

Ca 2+ channels and epilepsy

By Jones O.T.

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 211-225

Elsevier

Access to resources Recommend Favorite

Effect of CYP2C9 polymorphisms on pharmacokinetics of nateglinide

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The oral antihyperglycaemic agent nateglinide [`Starlix'] has been approved in Switzerland for the treatment of type 2 diabetes mellitus.

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite